Results 131 to 140 of about 387,869 (336)

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

open access: green, 1986
Yoshito Itoh   +9 more
openalex   +1 more source

Evaluating inclusiveness and diversity in health misinformation correction research: A scoping review

open access: yesHealth Information &Libraries Journal, EarlyView.
Abstract Background The inclusion of marginalized populations in health information research is crucial for ensuring equitable health outcomes and addressing systemic disparities. However, underrepresentation of these groups remains a significant issue, particularly in health misinformation correction research.
Romy RW, Junhan Chen, Yuan Wang
wiley   +1 more source

Morbidity and risk factors of COVID‐19 in people with HIV‐1 in Europe: A combined observational cohort and nested case–control study

open access: yesHIV Medicine, EarlyView.
Abstract Objective To study the COVID‐19 disease course in people living with HIV (PLWH) based on meaningful case numbers, information about comorbidities, antiretroviral and COVID‐19 treatment and HIV disease‐related variables. Methods Multi‐centre, observational, retrospective study of people living with HIV with COVID‐19 matched to HIV‐uninfected ...
Georg M. N. Behrens   +31 more
wiley   +1 more source

New hepatitis B vaccines.

open access: green, 1985
E M Vandervelde, P P Mortimer
openalex   +2 more sources

Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025

open access: yesHIV Medicine, EarlyView.
Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni   +19 more
wiley   +1 more source

Immunogenicity of Two Doses of Yeast Recombinant Hepatitis B Vaccine in Healthy Older Adults [PDF]

open access: bronze, 1997
Bruce G. Gellin   +6 more
openalex   +1 more source

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

open access: yesInternational Journal of Dermatology, EarlyView.
Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy